These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11748783)

  • 1. Psychosis and behavioural symptoms of dementia: defining the role of neuroleptic interventions.
    Lawlor B; Bhriain SN
    Int J Geriatr Psychiatry; 2001 Dec; 16 Suppl 1():S2-6. PubMed ID: 11748783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
    Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic treatment of psychosis and agitation in the elderly.
    Daniel DG
    J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agitation and psychosis in dementia.
    Ballard C
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):913-7. PubMed ID: 17974863
    [No Abstract]   [Full Text] [Related]  

  • 7. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
    Tune LE
    J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic treatment of agitation and psychosis in dementia.
    Devanand DP; Levy SR
    J Geriatr Psychiatry Neurol; 1995 Oct; 8 Suppl 1():S18-27. PubMed ID: 8561840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotic symptoms, aggression and restlessness in dementia.
    Ballard C; Gray A; Ayre G
    Rev Neurol (Paris); 1999; 155 Suppl 4():S44-52. PubMed ID: 10637938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of aggression, agitation, and psychosis in dementia: focus on atypical antipsychotics.
    Aupperle P
    Am J Alzheimers Dis Other Demen; 2006; 21(2):101-8. PubMed ID: 16634465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic use in dementia: the relationship between neuropsychiatric symptom profiles and adverse outcomes.
    Mueller C; John C; Perera G; Aarsland D; Ballard C; Stewart R
    Eur J Epidemiol; 2021 Jan; 36(1):89-101. PubMed ID: 32415541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Lyons B; Grossman F
    J Clin Psychiatry; 2003 Feb; 64(2):134-43. PubMed ID: 12633121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease.
    Lopez OL; Wisniewski SR; Becker JT; Boller F; DeKosky ST
    Arch Neurol; 1999 Oct; 56(10):1266-72. PubMed ID: 10520944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotics in the elderly.
    Rosen J; Bohon S; Gershon S
    Acta Psychiatr Scand Suppl; 1990; 358():170-5. PubMed ID: 1978479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of the elderly suffering from psychosis and dementia.
    Sunderland T
    J Clin Psychiatry; 1996; 57 Suppl 9():53-6. PubMed ID: 8823351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease.
    Creese B; Da Silva MV; Johar I; Ballard C
    Expert Rev Neurother; 2018 Jun; 18(6):461-467. PubMed ID: 29764230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
    Ballard C; Waite J
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD003476. PubMed ID: 16437455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyproheptadine treatment in neuroleptic-induced akathisia.
    Weiss D; Aizenberg D; Hermesh H; Zemishlany Z; Munitz H; Radwan M; Weizman A
    Br J Psychiatry; 1995 Oct; 167(4):483-6. PubMed ID: 8829717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.